Skip to content

Author

Zahid Rafiq

We have 3 of 36 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Tumor Treating Fields (TTFields) sensitize anti-PD1-resistant lung tumors to PD1 blockade and remodel myeloid and lymphoid states

TTFields sensitized anti-PD1-refractory lung tumors to PD1 blockade and induced coordinated remodeling of tumor-cell fitness and the tumor immune microenvironment, identifying TTFields as a potential tumor-conditioning strategy for overcoming resistance to immune checkpoint blockade.

Yun Hu, Fatemeh Maspourour, Qi Wang et al. · 0 citations
Review Open access Aug 2026

Quantum-Augmented Federated AI for Adaptive Pharmacogenomic Precision Oncology: A Perspective.

A forward-looking framework that integrates federated learning, pharmacogenomic digital twins, and hybrid quantum-classical optimization to support the development of adaptive, privacy-preserving precision oncology systems is proposed.

Zahid Rafiq, N. Puebla-Osorio · 0 citations
Open access Jul 2026

HSPiP, QbD, and Zeneth based green analysis and stability study of valsartan in the presence of mutagenic impurities: an in-silico study for predicting drug safety and quality control

The newly developed HSPiP, QbD, and Zeneth enabled stability-indicating UFLC method was environmentally sustainable, sensitive, accurate, reproducible, simple, rapid, economic, and reliable to detect even the trace degradants of VAL.

Madhav Shelke, Afzal Hussain, Chandrakant Bonde et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.